RU2014123316A - Ингибиторы фосфодиэстеразы типа 10а - Google Patents
Ингибиторы фосфодиэстеразы типа 10а Download PDFInfo
- Publication number
- RU2014123316A RU2014123316A RU2014123316/04A RU2014123316A RU2014123316A RU 2014123316 A RU2014123316 A RU 2014123316A RU 2014123316/04 A RU2014123316/04 A RU 2014123316/04A RU 2014123316 A RU2014123316 A RU 2014123316A RU 2014123316 A RU2014123316 A RU 2014123316A
- Authority
- RU
- Russia
- Prior art keywords
- ethyl
- quinolin
- pyridin
- thieno
- cyclopropyl
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 79
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 51
- 239000001257 hydrogen Substances 0.000 claims abstract 46
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract 38
- 229910052760 oxygen Inorganic materials 0.000 claims abstract 32
- 229910052717 sulfur Inorganic materials 0.000 claims abstract 29
- 125000005842 heteroatom Chemical group 0.000 claims abstract 28
- 229910052799 carbon Inorganic materials 0.000 claims abstract 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 18
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 17
- 229910052736 halogen Inorganic materials 0.000 claims abstract 17
- 150000002367 halogens Chemical class 0.000 claims abstract 17
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 14
- 125000001424 substituent group Chemical group 0.000 claims abstract 14
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims abstract 11
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims abstract 9
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract 7
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims abstract 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 5
- 125000002950 monocyclic group Chemical group 0.000 claims abstract 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims abstract 3
- -1 1,2-ethendiyl Chemical group 0.000 claims 145
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 65
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 43
- 150000002431 hydrogen Chemical class 0.000 claims 30
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 27
- 229920006395 saturated elastomer Polymers 0.000 claims 20
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 19
- 125000004159 quinolin-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C([H])C(*)=NC2=C1[H] 0.000 claims 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 13
- 125000001153 fluoro group Chemical group F* 0.000 claims 12
- IJAPPYDYQCXOEF-UHFFFAOYSA-N phthalazin-1(2H)-one Chemical compound C1=CC=C2C(=O)NN=CC2=C1 IJAPPYDYQCXOEF-UHFFFAOYSA-N 0.000 claims 11
- 125000000623 heterocyclic group Chemical group 0.000 claims 10
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 9
- 241000124008 Mammalia Species 0.000 claims 9
- 239000011737 fluorine Substances 0.000 claims 9
- 229910052731 fluorine Inorganic materials 0.000 claims 9
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims 9
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 9
- JEDVKUHCDPPWNR-UHFFFAOYSA-N 3h-thieno[2,3-d]pyrimidin-4-one Chemical compound O=C1NC=NC2=C1C=CS2 JEDVKUHCDPPWNR-UHFFFAOYSA-N 0.000 claims 8
- VXPLXMJHHKHSOA-UHFFFAOYSA-N propham Chemical compound CC(C)OC(=O)NC1=CC=CC=C1 VXPLXMJHHKHSOA-UHFFFAOYSA-N 0.000 claims 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 6
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical compound C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 claims 6
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 6
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 5
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 5
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 5
- 239000000126 substance Substances 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims 4
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 claims 4
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 3
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 3
- DUPNPBCUJHMSFZ-UHFFFAOYSA-N 5h-thieno[3,2-c]pyridin-4-one Chemical compound O=C1NC=CC2=C1C=CS2 DUPNPBCUJHMSFZ-UHFFFAOYSA-N 0.000 claims 3
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- 150000001204 N-oxides Chemical class 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 125000002837 carbocyclic group Chemical group 0.000 claims 3
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 3
- 150000004677 hydrates Chemical class 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 3
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000001054 5 membered carbocyclic group Chemical group 0.000 claims 2
- VOIKXRQSXFJVMT-UHFFFAOYSA-N 5h-thieno[2,3-d]pyridazin-4-one Chemical compound O=C1NN=CC2=C1C=CS2 VOIKXRQSXFJVMT-UHFFFAOYSA-N 0.000 claims 2
- KPOZQDBDLQTIGV-GHRIWEEISA-N 8-pyridin-4-yl-2-[(e)-2-quinolin-2-ylethenyl]isoquinolin-1-one Chemical compound C=12C(=O)N(\C=C\C=3N=C4C=CC=CC4=CC=3)C=CC2=CC=CC=1C1=CC=NC=C1 KPOZQDBDLQTIGV-GHRIWEEISA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- 208000012902 Nervous system disease Diseases 0.000 claims 2
- 208000025966 Neurological disease Diseases 0.000 claims 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims 2
- KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000002541 furyl group Chemical group 0.000 claims 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 125000001041 indolyl group Chemical group 0.000 claims 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 230000000926 neurological effect Effects 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 2
- 208000020016 psychiatric disease Diseases 0.000 claims 2
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 150000003254 radicals Chemical class 0.000 claims 2
- 201000000980 schizophrenia Diseases 0.000 claims 2
- 125000000335 thiazolyl group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-N 1-Piperidine carboxylic acid Chemical compound OC(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-N 0.000 claims 1
- 125000005983 2,5-diazabicyclo[2.2.1]heptan-2-yl group Chemical group 0.000 claims 1
- ATGDQZMISIVOEX-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-4,8-dipyridin-4-ylphthalazin-1-one Chemical compound C12=CC=CC(C=3C=CN=CC=3)=C2C(=O)N(CCC=2N=C3C=CC=CN3C=2)N=C1C1=CC=NC=C1 ATGDQZMISIVOEX-UHFFFAOYSA-N 0.000 claims 1
- HLTZFJMZKQGXKH-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-4-morpholin-4-ylphthalazin-1-one Chemical compound C12=CC=CC=C2C(=O)N(CCC=2N=C3C=CC=CN3C=2)N=C1N1CCOCC1 HLTZFJMZKQGXKH-UHFFFAOYSA-N 0.000 claims 1
- PZVOUFFDRRBEIU-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-4-pyrimidin-5-ylphthalazin-1-one Chemical compound C12=CC=CC=C2C(=O)N(CCC=2N=C3C=CC=CN3C=2)N=C1C1=CN=CN=C1 PZVOUFFDRRBEIU-UHFFFAOYSA-N 0.000 claims 1
- RVGGBBZQPFBCDN-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-5-morpholin-4-ylphthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=C1N1CCOCC1 RVGGBBZQPFBCDN-UHFFFAOYSA-N 0.000 claims 1
- BGHVTPXKDAVZDD-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-5-pyridin-3-ylphthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=C1C1=CC=CN=C1 BGHVTPXKDAVZDD-UHFFFAOYSA-N 0.000 claims 1
- YDEQSCDRKVMILG-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-5-pyridin-4-ylphthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=C1C1=CC=NC=C1 YDEQSCDRKVMILG-UHFFFAOYSA-N 0.000 claims 1
- VEUACMGMFIDCST-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-5-pyrimidin-5-ylphthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=C1C1=CN=CN=C1 VEUACMGMFIDCST-UHFFFAOYSA-N 0.000 claims 1
- LEDAISWHEVRGMO-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(1,2-oxazolidin-2-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N1CCCO1 LEDAISWHEVRGMO-UHFFFAOYSA-N 0.000 claims 1
- KGMRCSFKZMMGRS-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(1,3-oxazol-2-ylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NC1=NC=CO1 KGMRCSFKZMMGRS-UHFFFAOYSA-N 0.000 claims 1
- SNEHAQOYYRJELH-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(1,4-oxazepan-4-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N1CCCOCC1 SNEHAQOYYRJELH-UHFFFAOYSA-N 0.000 claims 1
- IXMPEMSGOMZKGC-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(1-methylpyrazol-3-yl)phthalazin-1-one Chemical compound CN1C=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CN5C=4)N=CC=3C=CC=2)=N1 IXMPEMSGOMZKGC-UHFFFAOYSA-N 0.000 claims 1
- OOLMPGZFHBLLPN-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(1-methylpyrazol-4-yl)phthalazin-1-one Chemical compound C1=NN(C)C=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 OOLMPGZFHBLLPN-UHFFFAOYSA-N 0.000 claims 1
- NZAAMDAAXLPMLH-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(1h-pyrazol-5-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C=1C=CNN=1 NZAAMDAAXLPMLH-UHFFFAOYSA-N 0.000 claims 1
- SKTBUCLTFLIQBW-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(2-methoxypyrimidin-5-yl)phthalazin-1-one Chemical compound C1=NC(OC)=NC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 SKTBUCLTFLIQBW-UHFFFAOYSA-N 0.000 claims 1
- GOPOXQNQVLGYPW-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(2-methylpyrimidin-5-yl)phthalazin-1-one Chemical compound C1=NC(C)=NC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 GOPOXQNQVLGYPW-UHFFFAOYSA-N 0.000 claims 1
- SAWLWXZQBGYFCB-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N(C1)CC21COC2 SAWLWXZQBGYFCB-UHFFFAOYSA-N 0.000 claims 1
- ZUIMMYOMYAIPIS-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(2-oxa-7-azaspiro[3.4]octan-7-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N(C1)CCC21COC2 ZUIMMYOMYAIPIS-UHFFFAOYSA-N 0.000 claims 1
- GUGMALZEBFWGRM-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(2-oxa-7-azaspiro[3.5]nonan-7-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N(CC1)CCC21COC2 GUGMALZEBFWGRM-UHFFFAOYSA-N 0.000 claims 1
- NVDGEXVYORQXAV-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(3-methoxypyridin-4-yl)phthalazin-1-one Chemical compound COC1=CN=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 NVDGEXVYORQXAV-UHFFFAOYSA-N 0.000 claims 1
- DZDFVQFBSZHODZ-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(4-methylpiperazin-1-yl)phthalazin-1-one Chemical compound C1CN(C)CCN1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 DZDFVQFBSZHODZ-UHFFFAOYSA-N 0.000 claims 1
- GHKGNRPMXWTDJJ-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(morpholin-4-ylmethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1CN1CCOCC1 GHKGNRPMXWTDJJ-UHFFFAOYSA-N 0.000 claims 1
- QYDOEPJNJJZBJP-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxan-3-ylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NC1CCCOC1 QYDOEPJNJJZBJP-UHFFFAOYSA-N 0.000 claims 1
- HOKNXJOOGBPPNC-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxan-4-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C1CCOCC1 HOKNXJOOGBPPNC-UHFFFAOYSA-N 0.000 claims 1
- CAJOMULDHTXCCJ-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxan-4-ylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NC1CCOCC1 CAJOMULDHTXCCJ-UHFFFAOYSA-N 0.000 claims 1
- DXCMCCZFNKZAMD-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxetan-3-ylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NC1COC1 DXCMCCZFNKZAMD-UHFFFAOYSA-N 0.000 claims 1
- MFNGOWHRKORXFO-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxetan-3-ylmethylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NCC1COC1 MFNGOWHRKORXFO-UHFFFAOYSA-N 0.000 claims 1
- BYBQUXPEWFXGOZ-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxetan-3-yloxy)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1OC1COC1 BYBQUXPEWFXGOZ-UHFFFAOYSA-N 0.000 claims 1
- PWXUZKKXTLUZSF-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxolan-3-yl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C1CCOC1 PWXUZKKXTLUZSF-UHFFFAOYSA-N 0.000 claims 1
- YGMWDYMNXOAZCG-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(oxolan-3-ylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NC1CCOC1 YGMWDYMNXOAZCG-UHFFFAOYSA-N 0.000 claims 1
- UJIVFCYJTRNPQW-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(piperidin-3-ylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NC1CCCNC1 UJIVFCYJTRNPQW-UHFFFAOYSA-N 0.000 claims 1
- ZTVMSECUCXZQCH-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(piperidin-4-ylamino)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1NC1CCNCC1 ZTVMSECUCXZQCH-UHFFFAOYSA-N 0.000 claims 1
- AZFURDPSTMAEGN-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-(pyridin-4-ylmethoxy)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1OCC1=CC=NC=C1 AZFURDPSTMAEGN-UHFFFAOYSA-N 0.000 claims 1
- YIXZIGNYQFLREH-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-[(1-methylazetidin-3-yl)amino]phthalazin-1-one Chemical compound C1N(C)CC1NC1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 YIXZIGNYQFLREH-UHFFFAOYSA-N 0.000 claims 1
- DZMUNMSUTQSARA-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-[(3-methyloxetan-3-yl)methylamino]phthalazin-1-one Chemical compound C=1C=CC=2C=NN(CCC=3N=C4C=CC=CN4C=3)C(=O)C=2C=1NCC1(C)COC1 DZMUNMSUTQSARA-UHFFFAOYSA-N 0.000 claims 1
- ZSOWUGHNYHMGKP-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-[2-(trifluoromethyl)morpholin-4-yl]phthalazin-1-one Chemical compound C1COC(C(F)(F)F)CN1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 ZSOWUGHNYHMGKP-UHFFFAOYSA-N 0.000 claims 1
- VQUXWBJKOCSWQH-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-[2-(trifluoromethyl)pyridin-4-yl]phthalazin-1-one Chemical compound C1=NC(C(F)(F)F)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CN5C=4)N=CC=3C=CC=2)=C1 VQUXWBJKOCSWQH-UHFFFAOYSA-N 0.000 claims 1
- MUIRKGPMSUPADS-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-[4-(trifluoromethyl)piperidin-1-yl]phthalazin-1-one Chemical compound C1CC(C(F)(F)F)CCN1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 MUIRKGPMSUPADS-UHFFFAOYSA-N 0.000 claims 1
- WMKPAWNMKJMZSQ-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-[methyl(oxetan-3-yl)amino]phthalazin-1-one Chemical compound C=1C=CC=2C=NN(CCC=3N=C4C=CC=CN4C=3)C(=O)C=2C=1N(C)C1COC1 WMKPAWNMKJMZSQ-UHFFFAOYSA-N 0.000 claims 1
- FUGFHQBNANOOEK-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-[methyl-[(3-methyloxetan-3-yl)methyl]amino]phthalazin-1-one Chemical compound C=1C=CC=2C=NN(CCC=3N=C4C=CC=CN4C=3)C(=O)C=2C=1N(C)CC1(C)COC1 FUGFHQBNANOOEK-UHFFFAOYSA-N 0.000 claims 1
- XPJZDWHNPGTAOG-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-morpholin-4-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N1CCOCC1 XPJZDWHNPGTAOG-UHFFFAOYSA-N 0.000 claims 1
- QYMINYZRMQLHLP-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-piperazin-1-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N1CCNCC1 QYMINYZRMQLHLP-UHFFFAOYSA-N 0.000 claims 1
- SDWQWDWHSDNWLU-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-piperidin-1-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N1CCCCC1 SDWQWDWHSDNWLU-UHFFFAOYSA-N 0.000 claims 1
- ILBALRRYSDZQQD-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-piperidin-4-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C1CCNCC1 ILBALRRYSDZQQD-UHFFFAOYSA-N 0.000 claims 1
- CRHZLJYSERGJMO-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-pyridazin-4-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C1=CC=NN=C1 CRHZLJYSERGJMO-UHFFFAOYSA-N 0.000 claims 1
- GRVGYMSXORAJPI-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-pyridin-3-yloxyphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1OC1=CC=CN=C1 GRVGYMSXORAJPI-UHFFFAOYSA-N 0.000 claims 1
- YTKDXEZBJIZKAR-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-pyridin-4-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C1=CC=NC=C1 YTKDXEZBJIZKAR-UHFFFAOYSA-N 0.000 claims 1
- CNYARIHSCWKDBT-UHFFFAOYSA-N 2-(2-imidazo[1,2-a]pyridin-2-ylethyl)-8-pyrimidin-5-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C1=CN=CN=C1 CNYARIHSCWKDBT-UHFFFAOYSA-N 0.000 claims 1
- YAKOTIWFALPZOJ-UHFFFAOYSA-N 2-(2-quinolin-2-ylethyl)-8-thiophen-2-ylphthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=CS1 YAKOTIWFALPZOJ-UHFFFAOYSA-N 0.000 claims 1
- PCVUPNNIMVDXTJ-UHFFFAOYSA-N 2-[2-(1,3-benzothiazol-2-yl)ethyl]-8-pyridin-4-ylisoquinolin-1-one Chemical compound C=12C(=O)N(CCC=3SC4=CC=CC=C4N=3)C=CC2=CC=CC=1C1=CC=NC=C1 PCVUPNNIMVDXTJ-UHFFFAOYSA-N 0.000 claims 1
- CSEIXJZKDKGRQL-UHFFFAOYSA-N 2-[2-(1,6-naphthyridin-2-yl)ethyl]-8-pyridin-4-ylisoquinolin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CN=CC4=CC=3)C=CC2=CC=CC=1C1=CC=NC=C1 CSEIXJZKDKGRQL-UHFFFAOYSA-N 0.000 claims 1
- VCCQOLDSXGLKJY-UHFFFAOYSA-N 2-[2-(1h-benzimidazol-2-yl)ethyl]-5-pyridin-4-ylphthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3NC4=CC=CC=C4N=3)N=CC2=C1C1=CC=NC=C1 VCCQOLDSXGLKJY-UHFFFAOYSA-N 0.000 claims 1
- RNZOPJWJVAXPFR-UHFFFAOYSA-N 2-[2-(3-methylquinolin-2-yl)ethyl]-8-pyridin-4-ylisoquinolin-1-one Chemical compound CC1=CC2=CC=CC=C2N=C1CCN(C(C1=2)=O)C=CC1=CC=CC=2C1=CC=NC=C1 RNZOPJWJVAXPFR-UHFFFAOYSA-N 0.000 claims 1
- GUSZZCFDFJEHQY-UHFFFAOYSA-N 2-[2-(5-methylpyridin-2-yl)ethyl]-8-pyridin-4-ylisoquinolin-1-one Chemical compound N1=CC(C)=CC=C1CCN1C(=O)C2=C(C=3C=CN=CC=3)C=CC=C2C=C1 GUSZZCFDFJEHQY-UHFFFAOYSA-N 0.000 claims 1
- IDRPQGPZVKLIFY-UHFFFAOYSA-N 2-[2-(6-methoxypyridin-2-yl)ethyl]-8-pyridin-4-ylisoquinolin-1-one Chemical compound COC1=CC=CC(CCN2C(C3=C(C=4C=CN=CC=4)C=CC=C3C=C2)=O)=N1 IDRPQGPZVKLIFY-UHFFFAOYSA-N 0.000 claims 1
- GBLUIIINCIVDDD-UHFFFAOYSA-N 2-[2-(8-fluoroquinolin-2-yl)ethyl]-8-pyridin-4-ylisoquinolin-1-one Chemical compound N1=C2C(F)=CC=CC2=CC=C1CCN(C(C1=2)=O)C=CC1=CC=CC=2C1=CC=NC=C1 GBLUIIINCIVDDD-UHFFFAOYSA-N 0.000 claims 1
- MCDDLRLLWOQIHT-UHFFFAOYSA-N 2-[4-[4-oxo-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-3-yl]phenyl]acetonitrile Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CC=C(CC#N)C=C1 MCDDLRLLWOQIHT-UHFFFAOYSA-N 0.000 claims 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- UMBMLDDVTGHFSQ-UHFFFAOYSA-N 3,7-dipyridin-4-yl-5-(2-pyridin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound N1=C(C=2C=CN=CC=2)C=2SC=C(C=3C=CN=CC=3)C=2C(=O)N1CCC1=CC=CC=N1 UMBMLDDVTGHFSQ-UHFFFAOYSA-N 0.000 claims 1
- ZFOQJELBBAXKQI-UHFFFAOYSA-N 3,7-dipyridin-4-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2SC=C(C=3C=CN=CC=3)C=2C(=O)N(CCC=2N=C3C=CC=CC3=CC=2)N=C1C1=CC=NC=C1 ZFOQJELBBAXKQI-UHFFFAOYSA-N 0.000 claims 1
- KAFNLLKMKIWPCP-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C2OCOC2=CC(C2=CSC=3C=NN(CCC=4N=C5C=CC=CC5=CC=4)C(C2=3)=O)=C1 KAFNLLKMKIWPCP-UHFFFAOYSA-N 0.000 claims 1
- ULMDVRBWINKKKT-UHFFFAOYSA-N 3-(1-benzofuran-2-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC=C2OC(C3=CSC=4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C3=4)=O)=CC2=C1 ULMDVRBWINKKKT-UHFFFAOYSA-N 0.000 claims 1
- IHOIKIWAGBXMTK-UHFFFAOYSA-N 3-(1-methylindol-5-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC=CC2=NC(CCN3N=CC=4SC=C(C=4C3=O)C=3C=C4C=CN(C4=CC=3)C)=CC=C21 IHOIKIWAGBXMTK-UHFFFAOYSA-N 0.000 claims 1
- IZLNFMAGGHABDR-UHFFFAOYSA-N 3-(1-methylpyrazol-4-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=NN(C)C=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 IZLNFMAGGHABDR-UHFFFAOYSA-N 0.000 claims 1
- JNSCTURGBBDPJR-UHFFFAOYSA-N 3-(1h-indazol-5-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C2NN=CC2=CC(C2=CSC=3C=NN(CCC=4N=C5C=CC=CC5=CC=4)C(C2=3)=O)=C1 JNSCTURGBBDPJR-UHFFFAOYSA-N 0.000 claims 1
- DCJOQZGUMMATNR-UHFFFAOYSA-N 3-(1h-indol-4-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CC=CC2=C1C=CN2 DCJOQZGUMMATNR-UHFFFAOYSA-N 0.000 claims 1
- UPPVMIBSCMUMFC-UHFFFAOYSA-N 3-(1h-indol-6-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C2C=CNC2=CC(C2=CSC=3C=NN(CCC=4N=C5C=CC=CC5=CC=4)C(C2=3)=O)=C1 UPPVMIBSCMUMFC-UHFFFAOYSA-N 0.000 claims 1
- BUEPDTHRTIHMEC-UHFFFAOYSA-N 3-(2,3-difluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1F BUEPDTHRTIHMEC-UHFFFAOYSA-N 0.000 claims 1
- FVDXMNXFJQEXSP-UHFFFAOYSA-N 3-(2,3-dihydro-1-benzofuran-5-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C2OCCC2=CC(C2=CSC=3C=NN(CCC=4N=C5C=CC=CC5=CC=4)C(C2=3)=O)=C1 FVDXMNXFJQEXSP-UHFFFAOYSA-N 0.000 claims 1
- XINPVAVWVVDEAK-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1OC XINPVAVWVVDEAK-UHFFFAOYSA-N 0.000 claims 1
- SDOXLUOIIPDGMK-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=CC(F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 SDOXLUOIIPDGMK-UHFFFAOYSA-N 0.000 claims 1
- UPJKOCYDAPUPBN-UHFFFAOYSA-N 3-(2,4-dimethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC(OC)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 UPJKOCYDAPUPBN-UHFFFAOYSA-N 0.000 claims 1
- HVDLBYARLPPWIF-UHFFFAOYSA-N 3-(2,4-dimethylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CC1=CC(C)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 HVDLBYARLPPWIF-UHFFFAOYSA-N 0.000 claims 1
- PUCCFQQFKJXEIK-UHFFFAOYSA-N 3-(2,5-dichlorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound ClC1=CC=C(Cl)C(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 PUCCFQQFKJXEIK-UHFFFAOYSA-N 0.000 claims 1
- QLKPJNKSMMRWIC-UHFFFAOYSA-N 3-(2,5-difluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=CC=C(F)C(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 QLKPJNKSMMRWIC-UHFFFAOYSA-N 0.000 claims 1
- JYRDMQKOYPEEMB-UHFFFAOYSA-N 3-(2,5-dimethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=C(OC)C(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 JYRDMQKOYPEEMB-UHFFFAOYSA-N 0.000 claims 1
- DNGAPPWFPQYXHZ-UHFFFAOYSA-N 3-(2-chloro-4-fluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound ClC1=CC(F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 DNGAPPWFPQYXHZ-UHFFFAOYSA-N 0.000 claims 1
- TWQSIYVSIGASMZ-UHFFFAOYSA-N 3-(2-chlorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound ClC1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 TWQSIYVSIGASMZ-UHFFFAOYSA-N 0.000 claims 1
- CAAYDVZTNZIUSM-UHFFFAOYSA-N 3-(2-ethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CCOC1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 CAAYDVZTNZIUSM-UHFFFAOYSA-N 0.000 claims 1
- XUPANYHEJOSCDA-UHFFFAOYSA-N 3-(2-ethylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CCC1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 XUPANYHEJOSCDA-UHFFFAOYSA-N 0.000 claims 1
- NMLZCHNXGCJDPI-UHFFFAOYSA-N 3-(2-fluoro-3-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1F NMLZCHNXGCJDPI-UHFFFAOYSA-N 0.000 claims 1
- RYORFSMHEDEJPU-UHFFFAOYSA-N 3-(2-fluoro-4-methylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=CC(C)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 RYORFSMHEDEJPU-UHFFFAOYSA-N 0.000 claims 1
- FVHHUOKOJFNQHF-UHFFFAOYSA-N 3-(2-fluoro-5-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=C(F)C(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 FVHHUOKOJFNQHF-UHFFFAOYSA-N 0.000 claims 1
- HJGIQUYRMXQHCG-UHFFFAOYSA-N 3-(2-fluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 HJGIQUYRMXQHCG-UHFFFAOYSA-N 0.000 claims 1
- IWSYGBCUTRXSMZ-UHFFFAOYSA-N 3-(2-hydroxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound OC1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 IWSYGBCUTRXSMZ-UHFFFAOYSA-N 0.000 claims 1
- ABRIEEOFOWGNFG-UHFFFAOYSA-N 3-(2-methoxy-5-methylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=C(C)C=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 ABRIEEOFOWGNFG-UHFFFAOYSA-N 0.000 claims 1
- FVIYJDJDXDTQKE-UHFFFAOYSA-N 3-(2-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 FVIYJDJDXDTQKE-UHFFFAOYSA-N 0.000 claims 1
- SPMRLIHQISMBCB-UHFFFAOYSA-N 3-(2-methoxypyridin-3-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=NC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 SPMRLIHQISMBCB-UHFFFAOYSA-N 0.000 claims 1
- YCTIMOAODOWOEI-UHFFFAOYSA-N 3-(2-methoxypyrimidin-5-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=NC(OC)=NC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 YCTIMOAODOWOEI-UHFFFAOYSA-N 0.000 claims 1
- ZYXIVTZVKLFZKM-UHFFFAOYSA-N 3-(2-methylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CC1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 ZYXIVTZVKLFZKM-UHFFFAOYSA-N 0.000 claims 1
- LJSRZOPHTPAEEZ-UHFFFAOYSA-N 3-(2-methylpyrazol-3-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CN1N=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 LJSRZOPHTPAEEZ-UHFFFAOYSA-N 0.000 claims 1
- MHRGRGWBBXZGIR-UHFFFAOYSA-N 3-(2-methylpyrazol-3-yl)-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound CN1N=CC=C1C1=CSC2=C1C(=O)N(CCC1=NC3=CC=CC=C3C=C1)C=C2 MHRGRGWBBXZGIR-UHFFFAOYSA-N 0.000 claims 1
- JMRQRIZTIIZPEI-UHFFFAOYSA-N 3-(2-methylpyridin-4-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=NC(C)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 JMRQRIZTIIZPEI-UHFFFAOYSA-N 0.000 claims 1
- CIIOAWIXDWJHJF-UHFFFAOYSA-N 3-(2-oxo-1,3-dihydroindol-6-yl)-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound C1=CC=CC2=NC(CCN3C=CC=4SC=C(C=4C3=O)C3=CC=C4CC(NC4=C3)=O)=CC=C21 CIIOAWIXDWJHJF-UHFFFAOYSA-N 0.000 claims 1
- SRTRAABNHYNHRN-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C(F)C(F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 SRTRAABNHYNHRN-UHFFFAOYSA-N 0.000 claims 1
- IPEHQBRQXCJXMI-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C(OC)C(OC)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 IPEHQBRQXCJXMI-UHFFFAOYSA-N 0.000 claims 1
- KFSIBWDMINRVGU-UHFFFAOYSA-N 3-(3,4-dimethylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C(C)C(C)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 KFSIBWDMINRVGU-UHFFFAOYSA-N 0.000 claims 1
- VBPCKGWTMWNDBQ-UHFFFAOYSA-N 3-(3,5-difluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=CC(F)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 VBPCKGWTMWNDBQ-UHFFFAOYSA-N 0.000 claims 1
- RFVNCAFZOXTBAU-UHFFFAOYSA-N 3-(3,5-dimethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC(OC)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 RFVNCAFZOXTBAU-UHFFFAOYSA-N 0.000 claims 1
- HPXIBHJLBJHPKR-UHFFFAOYSA-N 3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CC1=NOC(C)=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 HPXIBHJLBJHPKR-UHFFFAOYSA-N 0.000 claims 1
- MBGVVLXDXVCQGN-UHFFFAOYSA-N 3-(3-ethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CCOC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 MBGVVLXDXVCQGN-UHFFFAOYSA-N 0.000 claims 1
- VRDKPRWGIPWKAY-UHFFFAOYSA-N 3-(3-fluoro-4-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C(F)C(OC)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 VRDKPRWGIPWKAY-UHFFFAOYSA-N 0.000 claims 1
- NBVQYERGRIFTBT-UHFFFAOYSA-N 3-(3-fluoro-5-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC(F)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 NBVQYERGRIFTBT-UHFFFAOYSA-N 0.000 claims 1
- XIZJMWMNGPCFFF-UHFFFAOYSA-N 3-(3-fluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 XIZJMWMNGPCFFF-UHFFFAOYSA-N 0.000 claims 1
- WVFAYBUSNQRFQL-UHFFFAOYSA-N 3-(3-hydroxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound OC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 WVFAYBUSNQRFQL-UHFFFAOYSA-N 0.000 claims 1
- YLUAVPASONNKNY-UHFFFAOYSA-N 3-(3-hydroxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound OC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)C=CC=3SC=2)=C1 YLUAVPASONNKNY-UHFFFAOYSA-N 0.000 claims 1
- VLQOEPZOKPQTHP-UHFFFAOYSA-N 3-(3-hydroxypyridin-4-yl)-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound OC1=CN=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)C=C2 VLQOEPZOKPQTHP-UHFFFAOYSA-N 0.000 claims 1
- SSCOIHCJCLALID-UHFFFAOYSA-N 3-(3-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 SSCOIHCJCLALID-UHFFFAOYSA-N 0.000 claims 1
- JCZJEAVBOXBNIM-UHFFFAOYSA-N 3-(3-methoxypyridin-4-yl)-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound COC1=CN=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)C=C2 JCZJEAVBOXBNIM-UHFFFAOYSA-N 0.000 claims 1
- HISVDBNUIFMAEV-UHFFFAOYSA-N 3-(3-methylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 HISVDBNUIFMAEV-UHFFFAOYSA-N 0.000 claims 1
- ZRXFASXFGKYWSL-UHFFFAOYSA-N 3-(4,5-difluoro-2-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC(F)=C(F)C=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 ZRXFASXFGKYWSL-UHFFFAOYSA-N 0.000 claims 1
- QVWRXKGQVFZOOL-UHFFFAOYSA-N 3-(4-ethoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(OCC)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 QVWRXKGQVFZOOL-UHFFFAOYSA-N 0.000 claims 1
- QLLGSNSIQMHGCH-UHFFFAOYSA-N 3-(4-ethylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(CC)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 QLLGSNSIQMHGCH-UHFFFAOYSA-N 0.000 claims 1
- LEKKMNVDZORIHF-UHFFFAOYSA-N 3-(4-fluoro-2-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC(F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 LEKKMNVDZORIHF-UHFFFAOYSA-N 0.000 claims 1
- WFRMHEYXUIDBSD-UHFFFAOYSA-N 3-(4-fluoro-2-methylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CC1=CC(F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 WFRMHEYXUIDBSD-UHFFFAOYSA-N 0.000 claims 1
- BAUWWUYLSMLXDE-UHFFFAOYSA-N 3-(4-fluoro-3-methylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=C(F)C(C)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 BAUWWUYLSMLXDE-UHFFFAOYSA-N 0.000 claims 1
- HYVRQNWOIHSVIE-UHFFFAOYSA-N 3-(4-fluorophenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 HYVRQNWOIHSVIE-UHFFFAOYSA-N 0.000 claims 1
- FWTSFAIGMJGHNF-UHFFFAOYSA-N 3-(4-hydroxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(O)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 FWTSFAIGMJGHNF-UHFFFAOYSA-N 0.000 claims 1
- ZYKSSUUTHFODIP-UHFFFAOYSA-N 3-(4-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(OC)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 ZYKSSUUTHFODIP-UHFFFAOYSA-N 0.000 claims 1
- SGJXOCUUXPGHKQ-UHFFFAOYSA-N 3-(4-methoxypyridin-3-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=NC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 SGJXOCUUXPGHKQ-UHFFFAOYSA-N 0.000 claims 1
- YFMBLVALFCERPI-UHFFFAOYSA-N 3-(4-methylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(C)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 YFMBLVALFCERPI-UHFFFAOYSA-N 0.000 claims 1
- RDYGHZZGCVCTFA-UHFFFAOYSA-N 3-(4-propan-2-ylphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(C(C)C)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 RDYGHZZGCVCTFA-UHFFFAOYSA-N 0.000 claims 1
- RAQYNIRCJNRTMJ-UHFFFAOYSA-N 3-(5-fluoro-2-methoxyphenyl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CC=C(F)C=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 RAQYNIRCJNRTMJ-UHFFFAOYSA-N 0.000 claims 1
- JDGUULVDBSWWLL-UHFFFAOYSA-N 3-(5-methoxypyridin-3-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COC1=CN=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 JDGUULVDBSWWLL-UHFFFAOYSA-N 0.000 claims 1
- YHEMNUWGXLMLDC-UHFFFAOYSA-N 3-(6-methoxypyridin-3-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=NC(OC)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 YHEMNUWGXLMLDC-UHFFFAOYSA-N 0.000 claims 1
- CMDPRGIKUUDGPI-UHFFFAOYSA-N 3-(6-morpholin-4-ylpyridin-3-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C(C=N1)=CC=C1N1CCOCC1 CMDPRGIKUUDGPI-UHFFFAOYSA-N 0.000 claims 1
- ZDNPTHXSPSJNMQ-UHFFFAOYSA-N 3-(furan-3-yl)-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C=1C=COC=1 ZDNPTHXSPSJNMQ-UHFFFAOYSA-N 0.000 claims 1
- HDWZWZSDSQKEFK-UHFFFAOYSA-N 3-[3-(dimethylamino)phenyl]-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound CN(C)C1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 HDWZWZSDSQKEFK-UHFFFAOYSA-N 0.000 claims 1
- TZPCJCUERYPQHQ-UHFFFAOYSA-N 3-[3-(methoxymethyl)phenyl]-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound COCC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3SC=2)=C1 TZPCJCUERYPQHQ-UHFFFAOYSA-N 0.000 claims 1
- NWYBBEUETPVNJY-UHFFFAOYSA-N 3-[4-(dimethylamino)phenyl]-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(N(C)C)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 NWYBBEUETPVNJY-UHFFFAOYSA-N 0.000 claims 1
- FKUALGMIKPBSLW-UHFFFAOYSA-N 3-[4-oxo-3-(2-quinolin-2-ylethyl)phthalazin-5-yl]benzonitrile Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=CC(C#N)=C1 FKUALGMIKPBSLW-UHFFFAOYSA-N 0.000 claims 1
- NHDWNERLXZJDOX-UHFFFAOYSA-N 3-isoquinolin-4-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC=C2C(C3=CSC=4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C3=4)=O)=CN=CC2=C1 NHDWNERLXZJDOX-UHFFFAOYSA-N 0.000 claims 1
- ITIJUGYBZDLPAG-UHFFFAOYSA-N 3-isoquinolin-5-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound N1=CC=C2C(C3=CSC=4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C3=4)=O)=CC=CC2=C1 ITIJUGYBZDLPAG-UHFFFAOYSA-N 0.000 claims 1
- JTDSBKRNATZNEY-UHFFFAOYSA-N 3-methyl-4-[4-oxo-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-3-yl]benzonitrile Chemical compound CC1=CC(C#N)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 JTDSBKRNATZNEY-UHFFFAOYSA-N 0.000 claims 1
- XGUYQFMFVOSCNY-UHFFFAOYSA-N 3-methyl-7-pyridin-4-yl-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound C=1N(CCC=2N=C3C=CC=CC3=CC=2)C(=O)C=2C(C)=CSC=2C=1C1=CC=NC=C1 XGUYQFMFVOSCNY-UHFFFAOYSA-N 0.000 claims 1
- JRECDFQWSARPCO-UHFFFAOYSA-N 3-morpholin-4-yl-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)C=CC=2SC=C1N1CCOCC1 JRECDFQWSARPCO-UHFFFAOYSA-N 0.000 claims 1
- YAXLKDIIBKDITJ-UHFFFAOYSA-N 3-naphthalen-2-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC=CC2=CC(C3=CSC=4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C3=4)=O)=CC=C21 YAXLKDIIBKDITJ-UHFFFAOYSA-N 0.000 claims 1
- VLBVRYOYJYGBAE-UHFFFAOYSA-N 3-phenyl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CC=CC=C1 VLBVRYOYJYGBAE-UHFFFAOYSA-N 0.000 claims 1
- VPGCNSZZYKECJJ-UHFFFAOYSA-N 3-piperidin-4-yl-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)C=CC=2SC=C1C1CCNCC1 VPGCNSZZYKECJJ-UHFFFAOYSA-N 0.000 claims 1
- BPFGZUCGZGHFRD-UHFFFAOYSA-N 3-pyridin-3-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CC=CN=C1 BPFGZUCGZGHFRD-UHFFFAOYSA-N 0.000 claims 1
- SKSQYABGUVJJEB-UHFFFAOYSA-N 3-pyridin-4-yl-5-(2-pyridin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound N1=CC=2SC=C(C=3C=CN=CC=3)C=2C(=O)N1CCC1=CC=CC=N1 SKSQYABGUVJJEB-UHFFFAOYSA-N 0.000 claims 1
- DESVUEMSTZOZEE-UHFFFAOYSA-N 3-pyridin-4-yl-5-(2-quinolin-2-ylethyl)furo[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)C=CC=2OC=C1C1=CC=NC=C1 DESVUEMSTZOZEE-UHFFFAOYSA-N 0.000 claims 1
- QJXQBZZLXDICMT-UHFFFAOYSA-N 3-pyridin-4-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CC=NC=C1 QJXQBZZLXDICMT-UHFFFAOYSA-N 0.000 claims 1
- ZMDYNOAKXSXGDB-UHFFFAOYSA-N 3-pyridin-4-yl-5-(2-quinolin-2-ylethyl)thieno[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)C=CC=2SC=C1C1=CC=NC=C1 ZMDYNOAKXSXGDB-UHFFFAOYSA-N 0.000 claims 1
- OTQVJTJWFXTDLK-UHFFFAOYSA-N 3-pyridin-4-yl-5-(2-thieno[3,2-b]pyridin-5-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CSC4=CC=3)N=CC=2SC=C1C1=CC=NC=C1 OTQVJTJWFXTDLK-UHFFFAOYSA-N 0.000 claims 1
- FWOVGPICLCXZHT-UKTHLTGXSA-N 3-pyridin-4-yl-5-[(e)-2-quinolin-2-ylethenyl]thieno[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(\C=C\C=3N=C4C=CC=CC4=CC=3)C=CC=2SC=C1C1=CC=NC=C1 FWOVGPICLCXZHT-UKTHLTGXSA-N 0.000 claims 1
- OIYGMNYTGALGEQ-UHFFFAOYSA-N 3-pyridin-4-yl-5-[2-(5,6,7,8-tetrahydroquinolin-2-yl)ethyl]thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4CCCCC4=CC=3)N=CC=2SC=C1C1=CC=NC=C1 OIYGMNYTGALGEQ-UHFFFAOYSA-N 0.000 claims 1
- JIRYNXNYQFOFAU-UHFFFAOYSA-N 3-pyrimidin-5-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CN=CN=C1 JIRYNXNYQFOFAU-UHFFFAOYSA-N 0.000 claims 1
- HMECCLFCJDDNEH-UHFFFAOYSA-N 3-quinolin-3-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC=CC2=CC(C3=CSC=4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C3=4)=O)=CN=C21 HMECCLFCJDDNEH-UHFFFAOYSA-N 0.000 claims 1
- IXXONYPEYIBQBU-UHFFFAOYSA-N 3-quinolin-5-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC=C2C(C3=CSC=4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C3=4)=O)=CC=CC2=N1 IXXONYPEYIBQBU-UHFFFAOYSA-N 0.000 claims 1
- NVOZAEATMWXGLJ-UHFFFAOYSA-N 3-quinolin-6-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound N1=CC=CC2=CC(C3=CSC=4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C3=4)=O)=CC=C21 NVOZAEATMWXGLJ-UHFFFAOYSA-N 0.000 claims 1
- ZBZBBGGENJZXQQ-UHFFFAOYSA-N 4-(oxetan-3-ylamino)-6-(2-quinolin-2-ylethyl)pyrido[2,3-d]pyridazin-5-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=NC=CC=1NC1COC1 ZBZBBGGENJZXQQ-UHFFFAOYSA-N 0.000 claims 1
- DVILDTSYTHJFEX-UHFFFAOYSA-N 4-[4-oxo-3-(2-quinolin-2-ylethyl)phthalazin-5-yl]benzonitrile Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=C(C#N)C=C1 DVILDTSYTHJFEX-UHFFFAOYSA-N 0.000 claims 1
- RGCBXRYLVWWMEH-UHFFFAOYSA-N 4-[4-oxo-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-3-yl]benzonitrile Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CC=C(C#N)C=C1 RGCBXRYLVWWMEH-UHFFFAOYSA-N 0.000 claims 1
- SNDDOEOHYUBNTL-UHFFFAOYSA-N 4-morpholin-4-yl-6-(2-quinolin-2-ylethyl)pyrido[2,3-d]pyridazin-5-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=NC=CC=1N1CCOCC1 SNDDOEOHYUBNTL-UHFFFAOYSA-N 0.000 claims 1
- MRJYSRAHMFKHSB-UHFFFAOYSA-N 4-pyridin-3-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C12=CC=CC=C2C(=O)N(CCC=2N=C3C=CC=CC3=CC=2)N=C1C1=CC=CN=C1 MRJYSRAHMFKHSB-UHFFFAOYSA-N 0.000 claims 1
- AZGBNIZGMABJEK-UHFFFAOYSA-N 4-pyridin-4-yl-6-(2-quinolin-2-ylethyl)pyrido[2,3-d]pyridazin-5-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=NC=CC=1C1=CC=NC=C1 AZGBNIZGMABJEK-UHFFFAOYSA-N 0.000 claims 1
- DWHIRSWNWDXFMQ-UHFFFAOYSA-N 4h-pyridazin-5-one Chemical compound O=C1CC=NN=C1 DWHIRSWNWDXFMQ-UHFFFAOYSA-N 0.000 claims 1
- WZSXORXZGIVIER-UHFFFAOYSA-N 5-(1,1-dioxo-1,4-thiazinan-4-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=C1N1CCS(=O)(=O)CC1 WZSXORXZGIVIER-UHFFFAOYSA-N 0.000 claims 1
- MKPWXXGSRXDBMR-UHFFFAOYSA-N 5-(1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrol-5-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound N1=CC2=C(N3CC4COCC4C3)C=CC=C2C(=O)N1CCC1=CN(C=CC=C2)C2=N1 MKPWXXGSRXDBMR-UHFFFAOYSA-N 0.000 claims 1
- RIUPBWLBPKIHNC-UHFFFAOYSA-N 5-(2,2-difluoro-2-quinolin-2-ylethyl)-3-pyridin-4-ylthieno[2,3-d]pyridazin-4-one Chemical compound C=1C=C2C=CC=CC2=NC=1C(F)(F)CN(C(C=12)=O)N=CC=1SC=C2C1=CC=NC=C1 RIUPBWLBPKIHNC-UHFFFAOYSA-N 0.000 claims 1
- MZZKQGOPXKBFIO-UHFFFAOYSA-N 5-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-pyridin-4-ylfuro[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CN4C=3)C=CC=2OC=C1C1=CC=NC=C1 MZZKQGOPXKBFIO-UHFFFAOYSA-N 0.000 claims 1
- AAPUOJXPNUDEGU-UHFFFAOYSA-N 5-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-pyridin-4-ylthieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC=2SC=C1C1=CC=NC=C1 AAPUOJXPNUDEGU-UHFFFAOYSA-N 0.000 claims 1
- KSHUAOSXNXYTHL-UHFFFAOYSA-N 5-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-pyridin-4-ylthieno[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CN4C=3)C=CC=2SC=C1C1=CC=NC=C1 KSHUAOSXNXYTHL-UHFFFAOYSA-N 0.000 claims 1
- IRLXRKYHRIWIAT-UHFFFAOYSA-N 5-(2-quinolin-2-ylethyl)-3-(1,2,3,6-tetrahydropyridin-4-yl)thieno[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)C=CC=2SC=C1C1=CCNCC1 IRLXRKYHRIWIAT-UHFFFAOYSA-N 0.000 claims 1
- ATISANFQFYTXEY-UHFFFAOYSA-N 5-(2-quinolin-2-ylethyl)-3-(2,3,4-trifluorophenyl)thieno[2,3-d]pyridazin-4-one Chemical compound FC1=C(F)C(F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 ATISANFQFYTXEY-UHFFFAOYSA-N 0.000 claims 1
- WWMKQPOEEVFZBP-UHFFFAOYSA-N 5-(2-quinolin-2-ylethyl)-3-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyridazin-4-one Chemical compound FC(F)(F)C1=CC=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 WWMKQPOEEVFZBP-UHFFFAOYSA-N 0.000 claims 1
- JKSFRKPCZZEAHH-UHFFFAOYSA-N 5-(2-quinolin-2-ylethyl)-3-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyridazin-4-one Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CSC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 JKSFRKPCZZEAHH-UHFFFAOYSA-N 0.000 claims 1
- OZUSTWWQMHVVOX-UHFFFAOYSA-N 5-(2-quinolin-2-ylethyl)-3-thiophen-2-ylthieno[2,3-d]pyridazin-4-one Chemical compound C1=2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC=2SC=C1C1=CC=CS1 OZUSTWWQMHVVOX-UHFFFAOYSA-N 0.000 claims 1
- RWRGYTCBRXICLF-UHFFFAOYSA-N 5-(3-hydroxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound OC1=CC=CC(C=2C3=C(C(N(CCC=4N=C5C=CC=CC5=CC=4)N=C3)=O)C=CC=2)=C1 RWRGYTCBRXICLF-UHFFFAOYSA-N 0.000 claims 1
- PLTVGJQELISXRT-XYOKQWHBSA-N 5-[(e)-2-(1,3-benzothiazol-2-yl)ethenyl]-3-pyridin-4-ylthieno[3,2-c]pyridin-4-one Chemical compound C1=2C(=O)N(\C=C\C=3SC4=CC=CC=C4N=3)C=CC=2SC=C1C1=CC=NC=C1 PLTVGJQELISXRT-XYOKQWHBSA-N 0.000 claims 1
- WUSHTKKHBFTHNQ-XYOKQWHBSA-N 5-[(e)-2-(3-methylquinolin-2-yl)ethenyl]-3-pyridin-4-ylthieno[3,2-c]pyridin-4-one Chemical compound CC1=CC2=CC=CC=C2N=C1\C=C\N(C(C=12)=O)C=CC=1SC=C2C1=CC=NC=C1 WUSHTKKHBFTHNQ-XYOKQWHBSA-N 0.000 claims 1
- XOEVLTCSMYOOSC-XYOKQWHBSA-N 5-[(e)-2-(6-methoxyquinolin-2-yl)ethenyl]-3-pyridin-4-ylthieno[3,2-c]pyridin-4-one Chemical compound C1=CC2=CC(OC)=CC=C2N=C1\C=C\N(C(C=12)=O)C=CC=1SC=C2C1=CC=NC=C1 XOEVLTCSMYOOSC-XYOKQWHBSA-N 0.000 claims 1
- RYIZXDMCAXBLGG-UHFFFAOYSA-N 5-[2-(5-ethylpyridin-2-yl)ethyl]-3-pyridin-4-ylthieno[3,2-c]pyridin-4-one Chemical compound N1=CC(CC)=CC=C1CCN1C(=O)C(C(C=2C=CN=CC=2)=CS2)=C2C=C1 RYIZXDMCAXBLGG-UHFFFAOYSA-N 0.000 claims 1
- FAFSADVWNGOAQV-UHFFFAOYSA-N 5-[2-(6-fluoroquinolin-2-yl)ethyl]-3-pyridin-4-ylthieno[2,3-d]pyridazin-4-one Chemical compound C1=CC2=CC(F)=CC=C2N=C1CCN(C(C=12)=O)N=CC=1SC=C2C1=CC=NC=C1 FAFSADVWNGOAQV-UHFFFAOYSA-N 0.000 claims 1
- QYQWXGSTTRMWMX-UHFFFAOYSA-N 5-[2-(7-fluoroimidazo[1,2-a]pyridin-2-yl)ethyl]-3-pyridin-4-ylthieno[2,3-d]pyridazin-4-one Chemical compound N1=C2C=C(F)C=CN2C=C1CCN(C(C=12)=O)N=CC=1SC=C2C1=CC=NC=C1 QYQWXGSTTRMWMX-UHFFFAOYSA-N 0.000 claims 1
- ZKZYHJUFYIHZIS-UHFFFAOYSA-N 5-morpholin-4-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=C1N1CCOCC1 ZKZYHJUFYIHZIS-UHFFFAOYSA-N 0.000 claims 1
- MFGXCNXNPGFFGW-UHFFFAOYSA-N 5-pyridin-3-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=C1C1=CC=CN=C1 MFGXCNXNPGFFGW-UHFFFAOYSA-N 0.000 claims 1
- XHIMEOLPDDADGU-UHFFFAOYSA-N 5-pyridin-4-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=C1C1=CC=NC=C1 XHIMEOLPDDADGU-UHFFFAOYSA-N 0.000 claims 1
- BILLTUXMZNLKOD-UHFFFAOYSA-N 5-pyrimidin-5-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=C2C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=C1C1=CN=CN=C1 BILLTUXMZNLKOD-UHFFFAOYSA-N 0.000 claims 1
- FYNCIYHECMWXPK-UHFFFAOYSA-N 5h-furo[3,2-c]pyridin-4-one Chemical compound O=C1NC=CC2=C1C=CO2 FYNCIYHECMWXPK-UHFFFAOYSA-N 0.000 claims 1
- DHLCTHXZKHGREA-UHFFFAOYSA-N 6h-pyrido[2,3-d]pyridazin-5-one Chemical compound C1=CC=C2C(=O)NN=CC2=N1 DHLCTHXZKHGREA-UHFFFAOYSA-N 0.000 claims 1
- IKPPQKUZZDMBIY-UHFFFAOYSA-N 7-pyridin-4-yl-5-(2-quinolin-2-ylethyl)furo[3,2-c]pyridin-4-one Chemical compound C1=2OC=CC=2C(=O)N(CCC=2N=C3C=CC=CC3=CC=2)C=C1C1=CC=NC=C1 IKPPQKUZZDMBIY-UHFFFAOYSA-N 0.000 claims 1
- YVBSOAHXHUBZBG-UHFFFAOYSA-N 7-pyridin-4-yl-5-(2-quinolin-2-ylethyl)thieno[2,3-d]pyridazin-4-one Chemical compound C1=2SC=CC=2C(=O)N(CCC=2N=C3C=CC=CC3=CC=2)N=C1C1=CC=NC=C1 YVBSOAHXHUBZBG-UHFFFAOYSA-N 0.000 claims 1
- IVPQULUXGFANGE-UHFFFAOYSA-N 8-(1,1-dioxo-1,4-thiazinan-4-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N1CCS(=O)(=O)CC1 IVPQULUXGFANGE-UHFFFAOYSA-N 0.000 claims 1
- ANWMTJXMGCVPSL-UHFFFAOYSA-N 8-(1,1-dioxo-1,4-thiazinan-4-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1N1CCS(=O)(=O)CC1 ANWMTJXMGCVPSL-UHFFFAOYSA-N 0.000 claims 1
- VZVMSIYCOVYMAD-UHFFFAOYSA-N 8-(1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrol-5-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound N1=CC2=CC=CC(N3CC4COCC4C3)=C2C(=O)N1CCC1=CN(C=CC=C2)C2=N1 VZVMSIYCOVYMAD-UHFFFAOYSA-N 0.000 claims 1
- GYNDNUHIODKUEL-UHFFFAOYSA-N 8-(1,3-benzodioxol-5-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C2OCOC2=CC(C=2C=CC=C3C=NN(CCC=4N=C5C=CC=CC5=CC=4)C(C=23)=O)=C1 GYNDNUHIODKUEL-UHFFFAOYSA-N 0.000 claims 1
- GNKMKDNFUZPZGJ-UHFFFAOYSA-N 8-(1,3-dihydroisoindol-2-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1C2=CC=CC=C2CN1C(C=CC=C1C=N2)=C1C(=O)N2CCC1=CN(C=CC=C2)C2=N1 GNKMKDNFUZPZGJ-UHFFFAOYSA-N 0.000 claims 1
- LXVJRNOUEDUIIE-UHFFFAOYSA-N 8-(1-benzofuran-2-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=C2OC(C=3C=CC=C4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C=34)=O)=CC2=C1 LXVJRNOUEDUIIE-UHFFFAOYSA-N 0.000 claims 1
- CQKNFSSBFDPAIT-UHFFFAOYSA-N 8-(1-benzofuran-5-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C2OC=CC2=CC(C=2C=CC=C3C=NN(CCC=4N=C5C=CC=CC5=CC=4)C(C=23)=O)=C1 CQKNFSSBFDPAIT-UHFFFAOYSA-N 0.000 claims 1
- MIJXCCYQSOHRTK-UHFFFAOYSA-N 8-(1-methylindol-5-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=CC2=NC(CCN3N=CC=4C=CC=C(C=4C3=O)C=3C=C4C=CN(C4=CC=3)C)=CC=C21 MIJXCCYQSOHRTK-UHFFFAOYSA-N 0.000 claims 1
- VVOQHEUMTCCHMM-UHFFFAOYSA-N 8-(1-methylpyrazol-4-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=NN(C)C=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 VVOQHEUMTCCHMM-UHFFFAOYSA-N 0.000 claims 1
- MMRXOAWVKWYOFF-UHFFFAOYSA-N 8-(1h-indol-4-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=CC2=C1C=CN2 MMRXOAWVKWYOFF-UHFFFAOYSA-N 0.000 claims 1
- QGFFXJRVGBXMJF-UHFFFAOYSA-N 8-(1h-indol-5-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C2NC=CC2=CC(C=2C=CC=C3C=NN(CCC=4N=C5C=CC=CC5=CC=4)C(C=23)=O)=C1 QGFFXJRVGBXMJF-UHFFFAOYSA-N 0.000 claims 1
- HMVCKYIKOYKEAZ-UHFFFAOYSA-N 8-(2,3-difluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1F HMVCKYIKOYKEAZ-UHFFFAOYSA-N 0.000 claims 1
- SCXXDISADHSQQW-UHFFFAOYSA-N 8-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound O1CCOC2=CC(C=3C=CC=C4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C=34)=O)=CC=C21 SCXXDISADHSQQW-UHFFFAOYSA-N 0.000 claims 1
- SZIBUDQVFZLYQL-UHFFFAOYSA-N 8-(2,4-dimethoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC(OC)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 SZIBUDQVFZLYQL-UHFFFAOYSA-N 0.000 claims 1
- BNGIOLANESYJGX-UHFFFAOYSA-N 8-(2,5-difluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CC=C(F)C(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 BNGIOLANESYJGX-UHFFFAOYSA-N 0.000 claims 1
- GHCSQONACBFQCS-UHFFFAOYSA-N 8-(2,5-dimethoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC=C(OC)C(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 GHCSQONACBFQCS-UHFFFAOYSA-N 0.000 claims 1
- NMKHPDXEXSKWOZ-UHFFFAOYSA-N 8-(2,6-diazaspiro[3.5]nonan-6-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N(C1)CCCC21CNC2 NMKHPDXEXSKWOZ-UHFFFAOYSA-N 0.000 claims 1
- FUJSQVCEXWRUTI-UHFFFAOYSA-N 8-(2,6-dimethylmorpholin-4-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1C(C)OC(C)CN1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 FUJSQVCEXWRUTI-UHFFFAOYSA-N 0.000 claims 1
- YNMBGCQXVBXWRV-UHFFFAOYSA-N 8-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N(CC1)CCC21CNC2 YNMBGCQXVBXWRV-UHFFFAOYSA-N 0.000 claims 1
- AGCFZDDKWQPNRV-UHFFFAOYSA-N 8-(2,7-diazaspiro[4.4]nonan-2-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1N(C1)CCC21CCNC2 AGCFZDDKWQPNRV-UHFFFAOYSA-N 0.000 claims 1
- LHTPZOZMDHLOLP-UHFFFAOYSA-N 8-(2-chloro-4-fluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound ClC1=CC(F)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 LHTPZOZMDHLOLP-UHFFFAOYSA-N 0.000 claims 1
- PIJPDFOZENNOON-UHFFFAOYSA-N 8-(2-chlorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound ClC1=CC=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 PIJPDFOZENNOON-UHFFFAOYSA-N 0.000 claims 1
- MLVQZNVKMMRGCS-UHFFFAOYSA-N 8-(2-cyclopropylpyrimidin-5-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C(C=N1)=CN=C1C1CC1 MLVQZNVKMMRGCS-UHFFFAOYSA-N 0.000 claims 1
- HDIMXYLZNNQPNS-UHFFFAOYSA-N 8-(2-ethylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound CCC1=CC=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 HDIMXYLZNNQPNS-UHFFFAOYSA-N 0.000 claims 1
- GWZUSCSPXHLREQ-UHFFFAOYSA-N 8-(2-fluoro-3-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1F GWZUSCSPXHLREQ-UHFFFAOYSA-N 0.000 claims 1
- CRPXYLHFHXOXIA-UHFFFAOYSA-N 8-(2-fluoro-4-methylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CC(C)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 CRPXYLHFHXOXIA-UHFFFAOYSA-N 0.000 claims 1
- HGDWZYBPOHRWEG-UHFFFAOYSA-N 8-(2-fluoro-5-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC=C(F)C(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 HGDWZYBPOHRWEG-UHFFFAOYSA-N 0.000 claims 1
- GLTGKZUTXNYACM-UHFFFAOYSA-N 8-(2-fluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CC=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 GLTGKZUTXNYACM-UHFFFAOYSA-N 0.000 claims 1
- UWYXBOUXFFBGDZ-UHFFFAOYSA-N 8-(2-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 UWYXBOUXFFBGDZ-UHFFFAOYSA-N 0.000 claims 1
- NJEOVZBHBJGJBT-UHFFFAOYSA-N 8-(2-methoxypyridin-3-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=NC=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 NJEOVZBHBJGJBT-UHFFFAOYSA-N 0.000 claims 1
- YTLAMKCZSDOOMC-UHFFFAOYSA-N 8-(2-methylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound CC1=CC=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 YTLAMKCZSDOOMC-UHFFFAOYSA-N 0.000 claims 1
- BHRLRJMCBKPDIT-UHFFFAOYSA-N 8-(2-methylpyrazol-3-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound CN1N=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 BHRLRJMCBKPDIT-UHFFFAOYSA-N 0.000 claims 1
- JOJRFNRLHIGGAQ-UHFFFAOYSA-N 8-(2-methylpyridin-4-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=NC(C)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 JOJRFNRLHIGGAQ-UHFFFAOYSA-N 0.000 claims 1
- QNISTLHNQGTRFO-UHFFFAOYSA-N 8-(3,4-difluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C(F)C(F)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 QNISTLHNQGTRFO-UHFFFAOYSA-N 0.000 claims 1
- USEFFUABFNRNFQ-UHFFFAOYSA-N 8-(3,4-dihydro-2h-1,5-benzodioxepin-7-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound O1CCCOC2=CC(C=3C=CC=C4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C=34)=O)=CC=C21 USEFFUABFNRNFQ-UHFFFAOYSA-N 0.000 claims 1
- NIRIPGKCQSNTJJ-UHFFFAOYSA-N 8-(3,4-dihydro-2h-chromen-6-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound O1CCCC2=CC(C=3C=CC=C4C=NN(CCC=5N=C6C=CC=CN6C=5)C(C=34)=O)=CC=C21 NIRIPGKCQSNTJJ-UHFFFAOYSA-N 0.000 claims 1
- BWEJHNZISLZJHX-UHFFFAOYSA-N 8-(3,4-dimethoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 BWEJHNZISLZJHX-UHFFFAOYSA-N 0.000 claims 1
- DQVGRVRVQIFJIN-UHFFFAOYSA-N 8-(3,4-dimethylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C(C)C(C)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 DQVGRVRVQIFJIN-UHFFFAOYSA-N 0.000 claims 1
- JIRCMBTUPSBKDM-UHFFFAOYSA-N 8-(3,5-difluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CC(F)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 JIRCMBTUPSBKDM-UHFFFAOYSA-N 0.000 claims 1
- YJUMMXDZZOGXIJ-UHFFFAOYSA-N 8-(3,5-dimethoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC(OC)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 YJUMMXDZZOGXIJ-UHFFFAOYSA-N 0.000 claims 1
- USPNZGLIPIPHMG-UHFFFAOYSA-N 8-(3,5-dimethyl-1h-pyrazol-4-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound CC1=NNC(C)=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 USPNZGLIPIPHMG-UHFFFAOYSA-N 0.000 claims 1
- GAWJYLBMHMKZTQ-UHFFFAOYSA-N 8-(3-chloro-4-fluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C(Cl)C(F)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 GAWJYLBMHMKZTQ-UHFFFAOYSA-N 0.000 claims 1
- BFRDNLJBXSBZFE-UHFFFAOYSA-N 8-(3-fluoro-4-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=C(F)C(OC)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 BFRDNLJBXSBZFE-UHFFFAOYSA-N 0.000 claims 1
- RJIDRUVSCJEDIE-UHFFFAOYSA-N 8-(3-fluoro-5-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC(F)=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 RJIDRUVSCJEDIE-UHFFFAOYSA-N 0.000 claims 1
- ZWUJMPYIBCPCPW-UHFFFAOYSA-N 8-(3-fluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 ZWUJMPYIBCPCPW-UHFFFAOYSA-N 0.000 claims 1
- FNOVBOOFIYVYLI-UHFFFAOYSA-N 8-(3-hydroxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound OC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 FNOVBOOFIYVYLI-UHFFFAOYSA-N 0.000 claims 1
- ADWMCIGCCIDWOV-UHFFFAOYSA-N 8-(3-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 ADWMCIGCCIDWOV-UHFFFAOYSA-N 0.000 claims 1
- YEAMKDJHJDLGSV-UHFFFAOYSA-N 8-(3-methylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound CC1=CC=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 YEAMKDJHJDLGSV-UHFFFAOYSA-N 0.000 claims 1
- SSBGUENBVWTZDN-UHFFFAOYSA-N 8-(4,5-difluoro-2-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC(F)=C(F)C=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 SSBGUENBVWTZDN-UHFFFAOYSA-N 0.000 claims 1
- SPDNEWPCCKATPH-UHFFFAOYSA-N 8-(4,7-diazabicyclo[3.2.1]octan-7-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1C(NCC2)CC2N1C(C=CC=C1C=N2)=C1C(=O)N2CCC1=CN(C=CC=C2)C2=N1 SPDNEWPCCKATPH-UHFFFAOYSA-N 0.000 claims 1
- DSQRBAZCKPKNNG-UHFFFAOYSA-N 8-(4-ethylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC(CC)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 DSQRBAZCKPKNNG-UHFFFAOYSA-N 0.000 claims 1
- ZUDOREUYXPCAOS-UHFFFAOYSA-N 8-(4-fluoro-2-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC(F)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 ZUDOREUYXPCAOS-UHFFFAOYSA-N 0.000 claims 1
- AMRSVPSVBBXEHP-UHFFFAOYSA-N 8-(4-fluorophenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC(F)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 AMRSVPSVBBXEHP-UHFFFAOYSA-N 0.000 claims 1
- NHVDGQWAVIRLAB-UHFFFAOYSA-N 8-(4-hydroxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC(O)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 NHVDGQWAVIRLAB-UHFFFAOYSA-N 0.000 claims 1
- KOSLECQMKRVDJP-UHFFFAOYSA-N 8-(4-hydroxypiperidin-1-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1CC(O)CCN1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 KOSLECQMKRVDJP-UHFFFAOYSA-N 0.000 claims 1
- PASMGXRZNQPTIQ-UHFFFAOYSA-N 8-(4-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC(OC)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 PASMGXRZNQPTIQ-UHFFFAOYSA-N 0.000 claims 1
- YZNVYUPCDBYVDK-UHFFFAOYSA-N 8-(4-methylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC(C)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 YZNVYUPCDBYVDK-UHFFFAOYSA-N 0.000 claims 1
- OBLGCZAAFNWEEK-UHFFFAOYSA-N 8-(4-propan-2-ylphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC(C(C)C)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 OBLGCZAAFNWEEK-UHFFFAOYSA-N 0.000 claims 1
- KGGSKYQXRPEXPF-UHFFFAOYSA-N 8-(5-fluoro-2-methoxyphenyl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CC=C(F)C=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 KGGSKYQXRPEXPF-UHFFFAOYSA-N 0.000 claims 1
- LXGJGIKPAZRBBH-UHFFFAOYSA-N 8-(5-fluoropyridin-3-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CN=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 LXGJGIKPAZRBBH-UHFFFAOYSA-N 0.000 claims 1
- XBYIOBJIDZZOLI-UHFFFAOYSA-N 8-(5-methoxypyridin-3-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound COC1=CN=CC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CC5=CC=4)N=CC=3C=CC=2)=C1 XBYIOBJIDZZOLI-UHFFFAOYSA-N 0.000 claims 1
- OCQOVHUDZAGSKS-UHFFFAOYSA-N 8-(6-methoxypyridin-3-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=NC(OC)=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 OCQOVHUDZAGSKS-UHFFFAOYSA-N 0.000 claims 1
- CRMLDRMUJSVAKJ-UHFFFAOYSA-N 8-(furan-3-yl)-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CN4C=3)N=CC2=CC=CC=1C=1C=COC=1 CRMLDRMUJSVAKJ-UHFFFAOYSA-N 0.000 claims 1
- XBXQJODNYIFXRG-UHFFFAOYSA-N 8-(furan-3-yl)-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C=1C=COC=1 XBXQJODNYIFXRG-UHFFFAOYSA-N 0.000 claims 1
- TYLSRGVVYMTMQL-UHFFFAOYSA-N 8-[(1-acetylpiperidin-3-yl)amino]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1N(C(=O)C)CCCC1NC1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 TYLSRGVVYMTMQL-UHFFFAOYSA-N 0.000 claims 1
- WYHULGFAYFYQOK-UHFFFAOYSA-N 8-[(1-acetylpiperidin-4-yl)amino]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1CN(C(=O)C)CCC1NC1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 WYHULGFAYFYQOK-UHFFFAOYSA-N 0.000 claims 1
- IJPREFCEFQXMFI-ROUUACIJSA-N 8-[(1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=CC2=NC(CCN3N=CC=4C=CC=C(C=4C3=O)N3C[C@]4(NC[C@]3([H])C4)[H])=CN21 IJPREFCEFQXMFI-ROUUACIJSA-N 0.000 claims 1
- SPDWRQMREDRMBU-FUHWJXTLSA-N 8-[(1s,5s)-3,6-diazabicyclo[3.2.0]heptan-3-yl]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound N1=CC2=CC=CC(N3C[C@H]4NC[C@H]4C3)=C2C(=O)N1CCC1=CN(C=CC=C2)C2=N1 SPDWRQMREDRMBU-FUHWJXTLSA-N 0.000 claims 1
- VIQRKAXKNCTFIL-GOSISDBHSA-N 8-[(3r)-3-hydroxypiperidin-1-yl]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1[C@H](O)CCCN1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 VIQRKAXKNCTFIL-GOSISDBHSA-N 0.000 claims 1
- VIQRKAXKNCTFIL-SFHVURJKSA-N 8-[(3s)-3-hydroxypiperidin-1-yl]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1[C@@H](O)CCCN1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CN3C=1)N=C2 VIQRKAXKNCTFIL-SFHVURJKSA-N 0.000 claims 1
- MBZYXTRDGUBSIB-UHFFFAOYSA-N 8-[1-(2-methylpropyl)pyrazol-4-yl]-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=NN(CC(C)C)C=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 MBZYXTRDGUBSIB-UHFFFAOYSA-N 0.000 claims 1
- GOKKCGWUSHZOSO-UHFFFAOYSA-N 8-[2-(3,4-difluorophenyl)morpholin-4-yl]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1=C(F)C(F)=CC=C1C1OCCN(C=2C=3C(=O)N(CCC=4N=C5C=CC=CN5C=4)N=CC=3C=CC=2)C1 GOKKCGWUSHZOSO-UHFFFAOYSA-N 0.000 claims 1
- DBODMJJTQKUAIC-UHFFFAOYSA-N 8-[2-(3-fluorophenyl)morpholin-4-yl]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound FC1=CC=CC(C2OCCN(C2)C=2C=3C(=O)N(CCC=4N=C5C=CC=CN5C=4)N=CC=3C=CC=2)=C1 DBODMJJTQKUAIC-UHFFFAOYSA-N 0.000 claims 1
- YNUMIMIPUOEQKI-UHFFFAOYSA-N 8-[2-(4-chlorophenyl)morpholin-4-yl]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC(Cl)=CC=C1C1OCCN(C=2C=3C(=O)N(CCC=4N=C5C=CC=CN5C=4)N=CC=3C=CC=2)C1 YNUMIMIPUOEQKI-UHFFFAOYSA-N 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- BUGIYVUGGJNZSQ-OROMBRFGSA-N 8-[[(3ar,4s,6as)-2-benzyl-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-4-yl]methylamino]-2-(2-imidazo[1,2-a]pyridin-2-ylethyl)phthalazin-1-one Chemical compound C([C@H]1CC[C@@H]([C@H]1C1)CNC=2C=CC=C3C=NN(CCC=4N=C5C=CC=CN5C=4)C(C=23)=O)N1CC1=CC=CC=C1 BUGIYVUGGJNZSQ-OROMBRFGSA-N 0.000 claims 1
- VYQPHXMQBVIWAQ-OPYAIIAOSA-N 8-[[(3as,4s,6as)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-4-yl]methylamino]-2-[2-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl)ethyl]phthalazin-1-one Chemical compound N1=CC2=CC=CC(NC[C@@H]3[C@H]4CNC[C@H]4CC3)=C2C(=O)N1CCC1=CN(CCCC2)C2=N1 VYQPHXMQBVIWAQ-OPYAIIAOSA-N 0.000 claims 1
- VWJIBWOVEOCMLC-UHFFFAOYSA-N 8-naphthalen-2-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=CC2=CC(C=3C=CC=C4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C=34)=O)=CC=C21 VWJIBWOVEOCMLC-UHFFFAOYSA-N 0.000 claims 1
- SPOXUQKAORHVPZ-UHFFFAOYSA-N 8-phenyl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=CC=C1 SPOXUQKAORHVPZ-UHFFFAOYSA-N 0.000 claims 1
- QEGSAUPKYWNROX-UHFFFAOYSA-N 8-piperidin-4-yl-2-[2-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-yl)ethyl]phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4CCCCN4C=3)N=CC2=CC=CC=1C1CCNCC1 QEGSAUPKYWNROX-UHFFFAOYSA-N 0.000 claims 1
- UGZYEVNNJNSNHU-UHFFFAOYSA-N 8-pyridin-3-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=CN=C1 UGZYEVNNJNSNHU-UHFFFAOYSA-N 0.000 claims 1
- FFRMASCYWRZWMG-UHFFFAOYSA-N 8-pyridin-4-yl-2-(1-quinolin-2-ylpropan-2-yl)isoquinolin-1-one Chemical compound C=1C=C2C=CC=CC2=NC=1CC(C)N(C(C1=2)=O)C=CC1=CC=CC=2C1=CC=NC=C1 FFRMASCYWRZWMG-UHFFFAOYSA-N 0.000 claims 1
- FXSVKGDGQZAEMN-UHFFFAOYSA-N 8-pyridin-4-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=NC=C1 FXSVKGDGQZAEMN-UHFFFAOYSA-N 0.000 claims 1
- LNUGJMVVSXZAIJ-UHFFFAOYSA-N 8-pyridin-4-yl-2-(2-quinolin-2-ylethyl)pyrido[3,4-d]pyridazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CN=CC=1C1=CC=NC=C1 LNUGJMVVSXZAIJ-UHFFFAOYSA-N 0.000 claims 1
- DSBQLIPPWLAUAO-RVDMUPIBSA-N 8-pyridin-4-yl-2-[(e)-2-quinazolin-2-ylethenyl]isoquinolin-1-one Chemical compound C=12C(=O)N(\C=C\C=3N=C4C=CC=CC4=CN=3)C=CC2=CC=CC=1C1=CC=NC=C1 DSBQLIPPWLAUAO-RVDMUPIBSA-N 0.000 claims 1
- QTAYILSEAREWPM-NTCAYCPXSA-N 8-pyridin-4-yl-2-[(e)-2-quinolin-2-ylethenyl]phthalazin-1-one Chemical compound C=12C(=O)N(\C=C\C=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CC=NC=C1 QTAYILSEAREWPM-NTCAYCPXSA-N 0.000 claims 1
- ARDQUSAPLNXNNB-UHFFFAOYSA-N 8-pyrimidin-5-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C=12C(=O)N(CCC=3N=C4C=CC=CC4=CC=3)N=CC2=CC=CC=1C1=CN=CN=C1 ARDQUSAPLNXNNB-UHFFFAOYSA-N 0.000 claims 1
- YKMDALRGEMWMID-UHFFFAOYSA-N 8-quinolin-3-yl-2-(2-quinolin-2-ylethyl)phthalazin-1-one Chemical compound C1=CC=CC2=CC(C=3C=CC=C4C=NN(CCC=5N=C6C=CC=CC6=CC=5)C(C=34)=O)=CN=C21 YKMDALRGEMWMID-UHFFFAOYSA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 208000019022 Mood disease Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 230000036506 anxiety Effects 0.000 claims 1
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 150000007942 carboxylates Chemical class 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 1
- NALBLJLOBICXRH-UHFFFAOYSA-N dinitrogen monohydride Chemical compound N=[N] NALBLJLOBICXRH-UHFFFAOYSA-N 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 1
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 claims 1
- GDOYRXLOYQAJMX-UHFFFAOYSA-N tert-butyl 2-[4-oxo-3-(2-quinolin-2-ylethyl)phthalazin-5-yl]pyrrole-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1C=CC=C1C1=CC=CC2=C1C(=O)N(CCC=1N=C3C=CC=CC3=CC=1)N=C2 GDOYRXLOYQAJMX-UHFFFAOYSA-N 0.000 claims 1
- WBKWUMSLHSFPNU-UHFFFAOYSA-N tert-butyl 4-[3-(2-imidazo[1,2-a]pyridin-2-ylethyl)-4-oxophthalazin-5-yl]-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC(C=2C=3C(=O)N(CCC=4N=C5C=CC=CN5C=4)N=CC=3C=CC=2)=C1 WBKWUMSLHSFPNU-UHFFFAOYSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000004571 thiomorpholin-4-yl group Chemical group N1(CCSCC1)* 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 0 *C(*1)=C(*)C(C(*(*I)C=*)=*)=C1N Chemical compound *C(*1)=C(*)C(C(*(*I)C=*)=*)=C1N 0.000 description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161557874P | 2011-11-09 | 2011-11-09 | |
| US61/557,874 | 2011-11-09 | ||
| PCT/EP2012/072150 WO2013068470A1 (en) | 2011-11-09 | 2012-11-08 | Inhibitors of phosphodiesterase type 10a |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014123316A true RU2014123316A (ru) | 2015-12-20 |
Family
ID=47178004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014123316/04A RU2014123316A (ru) | 2011-11-09 | 2012-11-08 | Ингибиторы фосфодиэстеразы типа 10а |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20130116241A1 (enExample) |
| EP (1) | EP2776418B1 (enExample) |
| JP (1) | JP2014534976A (enExample) |
| KR (1) | KR20140097318A (enExample) |
| CN (1) | CN104053654A (enExample) |
| AR (1) | AR088801A1 (enExample) |
| AU (1) | AU2012334074A1 (enExample) |
| BR (1) | BR112014011284A2 (enExample) |
| CA (1) | CA2852604A1 (enExample) |
| CL (1) | CL2014001212A1 (enExample) |
| CO (1) | CO7030959A2 (enExample) |
| CR (1) | CR20140223A (enExample) |
| DO (1) | DOP2014000097A (enExample) |
| ES (1) | ES2620531T3 (enExample) |
| GT (1) | GT201400089A (enExample) |
| HK (1) | HK1201519A1 (enExample) |
| IL (1) | IL232358A0 (enExample) |
| MX (1) | MX2014005714A (enExample) |
| PE (1) | PE20141938A1 (enExample) |
| PH (1) | PH12014500877A1 (enExample) |
| RU (1) | RU2014123316A (enExample) |
| SG (1) | SG11201402142VA (enExample) |
| TW (1) | TW201326153A (enExample) |
| UY (1) | UY34445A (enExample) |
| WO (1) | WO2013068470A1 (enExample) |
| ZA (1) | ZA201402966B (enExample) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130116241A1 (en) | 2011-11-09 | 2013-05-09 | Abbvie Inc. | Novel inhibitor compounds of phosphodiesterase type 10a |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| US9200005B2 (en) * | 2013-03-13 | 2015-12-01 | AbbVie Deutschland GmbH & Co. KG | Inhibitor compounds of phosphodiesterase type 10A |
| KR20160005365A (ko) | 2013-05-10 | 2016-01-14 | 님버스 아폴로, 인코포레이티드 | Acc 억제제 및 이의 용도 |
| WO2014182950A1 (en) * | 2013-05-10 | 2014-11-13 | Nimbus Apollo, Inc. | Acc inhibitors and uses thereof |
| HK1221411A1 (zh) | 2013-05-10 | 2017-06-02 | Gilead Apollo, Inc. | Acc抑制剂和其用途 |
| EA201591959A1 (ru) | 2013-05-10 | 2016-03-31 | Нимбус Аполло, Инк. | Ингибиторы акк и их применение |
| US9249163B2 (en) | 2013-06-11 | 2016-02-02 | Janssen Pharmaceutica Nv. | PDE10a inhibitors for the treatment of type II diabetes |
| WO2014200882A1 (en) | 2013-06-11 | 2014-12-18 | Janssen Pharmaceutica Nv | PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES |
| US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
| EP3126354B1 (en) * | 2014-04-04 | 2020-01-22 | H. Lundbeck A/S | Halogenated quinazolin-thf-amines as pde1 inhibitors |
| RU2659070C9 (ru) * | 2014-04-23 | 2018-08-24 | Дарт Нейросайенс (Кайман) Лтд. | ЗАМЕЩЕННЫЕ [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИН-7-ИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE2 |
| GB201416352D0 (en) * | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
| MA41291A (fr) | 2014-12-30 | 2017-11-07 | Forma Therapeutics Inc | Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer |
| TWI770525B (zh) | 2014-12-30 | 2022-07-11 | 美商瓦洛健康公司 | 作為泛素特異性蛋白酶７抑制劑之吡咯并及吡唑并嘧啶 |
| HK1248220A1 (zh) | 2015-02-05 | 2018-10-12 | Forma Therapeutics, Inc. | 喹唑啉酮和偶氮喹唑啉作为泛特丁胺蛋白酶7抑制剂 |
| HK1248222A1 (zh) | 2015-02-05 | 2018-10-12 | Forma Therapeutics, Inc. | 噻吩并嘧啶酮作为泛素特异性蛋白酶7抑制剂 |
| JP2018504432A (ja) | 2015-02-05 | 2018-02-15 | フォーマ セラピューティクス，インコーポレイテッド | ユビキチン特異的プロテアーゼ７阻害物質としてのイソチアゾロピリミジノン、ピラゾロピリミジノン及びピロロピリミジノン |
| EP3317277B1 (en) | 2015-07-01 | 2021-01-20 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| CN105669680B (zh) * | 2016-03-24 | 2018-02-23 | 南京药捷安康生物科技有限公司 | 吡咯并[2,1‑f][1,2,4]三嗪‑4(1H)‑酮衍生物类PDE9A抑制剂 |
| GEP20207167B (en) | 2016-06-22 | 2020-10-12 | Univ Vanderbilt | Positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
| JP7098167B2 (ja) * | 2016-11-07 | 2022-07-11 | ヴァンダービルト ユニヴァーシティ | ムスカリン性アセチルコリンレセプターｍ４のポジティブアロステリック調節因子 |
| US10961253B2 (en) | 2016-11-07 | 2021-03-30 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| CN109863139B (zh) | 2016-11-07 | 2023-02-17 | 范德比尔特大学 | 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂 |
| CN108084199A (zh) * | 2017-06-13 | 2018-05-29 | 长沙理工大学 | 一种合成呋喃并[3,2-c]吡啶-4(5H)-酮衍生物的方法 |
| EP3658560A4 (en) | 2017-07-25 | 2021-01-06 | Crinetics Pharmaceuticals, Inc. | SOMATOSTAT IN MODULATORS AND USES THEREOF |
| WO2019058393A1 (en) | 2017-09-22 | 2019-03-28 | Jubilant Biosys Limited | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PAD |
| FI3697785T3 (fi) | 2017-10-18 | 2023-04-03 | Jubilant Epipad LLC | Imidatsopyridiiniyhdisteitä pad:n estäjinä |
| AU2018362046B2 (en) | 2017-11-06 | 2023-04-13 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation |
| BR112020010322A2 (pt) | 2017-11-24 | 2020-11-17 | Jubilant Episcribe Llc | composto da fórmula i; composto da fórmula ia; composto da fórmula ib; processo de preparação de compostos da fórmula i; composição farmacêutica; método para o tratamento e/ou prevenção de várias doenças; uso dos compostos; método para o tratamento de câncer; e método para o tratamento e/ou prevenção de uma afecção mediada por prmt5 ou um distúrbio proliferativo ou câncer |
| US11376254B2 (en) | 2017-12-05 | 2022-07-05 | Vanderbilt University | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 |
| TW201930311A (zh) | 2017-12-05 | 2019-08-01 | 泛德比爾特大學 | 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑 |
| CN112105610B (zh) | 2018-03-13 | 2024-01-26 | 朱比连特普罗德尔有限责任公司 | 作为pd1/pd-l1相互作用/活化的抑制剂的双环化合物 |
| JP2021519786A (ja) | 2018-03-30 | 2021-08-12 | バイオセリックス， インコーポレイテッド | チエノピリミジノン化合物 |
| EP4429663A4 (en) * | 2021-11-09 | 2025-09-17 | Vigil Neuroscience Inc | HETEROCYCLIC COMPOUNDS USED AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL AGONISTS 2 |
Family Cites Families (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03120857A (ja) * | 1989-10-04 | 1991-05-23 | Ibiden Co Ltd | 電子部品塔載装置 |
| JP3120857B2 (ja) * | 1990-02-19 | 2000-12-25 | 中外製薬株式会社 | 新規な縮合複素環化合物とこれを用いた抗喘息剤 |
| US5380721A (en) * | 1990-09-10 | 1995-01-10 | Sterling Winthrop Inc. | Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents |
| DE69229874T2 (de) | 1991-10-09 | 1999-12-09 | Syntex (U.S.A.) Inc., Palo Alto | Pyrido pyridazinon und pyridazinthionverbindungen mit pde iv inhibierender wirkung |
| CA2104060A1 (en) | 1992-11-10 | 1994-05-11 | Robert Ed Johnson | Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents |
| CN1045962C (zh) * | 1993-01-01 | 1999-10-27 | 森德克斯(美国)股份有限公司 | 吡啶并哒嗪酮或吡啶并哒嗪硫酮化合物,制备它的中间体,含它的药物组合物及其用途 |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| DK1019385T3 (da) | 1995-09-15 | 2004-05-24 | Upjohn Co | Aminoaryloxazolidinon-N-oxider |
| US20030220234A1 (en) | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
| GB9918037D0 (en) | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
| US20030032579A1 (en) | 2001-04-20 | 2003-02-13 | Pfizer Inc. | Therapeutic use of selective PDE10 inhibitors |
| US20030166476A1 (en) | 2002-01-31 | 2003-09-04 | Winemiller Mark D. | Lubricating oil compositions with improved friction properties |
| JP2007508241A (ja) | 2003-07-31 | 2007-04-05 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | Ｐｄｅ１０ａ阻害剤を用いる糖尿病および関連障害の処置方法 |
| WO2005099353A2 (en) | 2004-04-19 | 2005-10-27 | Symed Labs Limited | A novel process for the preparation of linezolid and related compounds |
| CA2568929A1 (en) | 2004-06-07 | 2005-12-22 | Pfizer Products Inc. | Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions |
| PL1768967T3 (pl) | 2004-07-20 | 2009-09-30 | Symed Labs Ltd | Nowe związki pośrednie do wytwarzania linezolidu oraz związki pokrewne |
| WO2006028957A1 (en) | 2004-09-03 | 2006-03-16 | Memory Pharmaceuticals Corporation | 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| JP2008514702A (ja) | 2004-09-29 | 2008-05-08 | エーエムアール テクノロジー インコーポレイテッド | 新規シクロスポリン類似体およびそれらの薬学的使用 |
| TW200716636A (en) | 2005-05-31 | 2007-05-01 | Speedel Experimenta Ag | Heterocyclic spiro-compounds |
| EP1940819A1 (en) | 2005-08-16 | 2008-07-09 | Memory Pharmaceuticals Corporation | Phosphodiesterase 10 inhibitors |
| US7514068B2 (en) | 2005-09-14 | 2009-04-07 | Concert Pharmaceuticals Inc. | Biphenyl-pyrazolecarboxamide compounds |
| NL2000397C2 (nl) | 2006-01-05 | 2007-10-30 | Pfizer Prod Inc | Bicyclische heteroarylverbindingen als PDE10 inhibitoren. |
| WO2007082546A1 (en) | 2006-01-20 | 2007-07-26 | H. Lundbeck A/S | Use of tofisopam as a pde10a inhibitor |
| EP1981868A2 (en) | 2006-01-27 | 2008-10-22 | Pfizer Products Inc. | Aminophthalazine derivative compounds |
| EP1991530A1 (en) | 2006-02-21 | 2008-11-19 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| MX2008010671A (es) | 2006-02-21 | 2008-10-01 | Amgen Inc | Derivados de cinolina como inhibidores de fosfodiesterasa 10. |
| EP1996587A1 (en) | 2006-02-23 | 2008-12-03 | Pfizer Products Incorporated | Substituted quinazolines as pde10 inhibitors |
| WO2007100880A1 (en) | 2006-02-28 | 2007-09-07 | Amgen Inc. | Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| US20070265258A1 (en) | 2006-03-06 | 2007-11-15 | Ruiping Liu | Quinazoline derivatives as phosphodiesterase 10 inhibitors |
| MX2008011257A (es) | 2006-03-08 | 2008-09-25 | Amgen Inc | Derivados de quinolina e isoquinolina como inhibidores de fosfodiesterasa 10. |
| TW200817400A (en) | 2006-05-30 | 2008-04-16 | Elbion Ag | Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
| TW200815436A (en) | 2006-05-30 | 2008-04-01 | Elbion Ag | 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
| CA2654394A1 (en) | 2006-06-26 | 2008-01-03 | Pfizer Products Inc. | Tricyclic heteroaryl compounds as pde10 inhibitors |
| US20080090834A1 (en) | 2006-07-06 | 2008-04-17 | Pfizer Inc | Selective azole pde10a inhibitor compounds |
| PT2057153E (pt) | 2006-07-10 | 2012-11-14 | Lundbeck & Co As H | Derivados (3-aril-piperazin-1-il) de 6,7- dialcoxiquinazolina, 6,7-dialcoxiftalazina e 6,7-dialcoxiisoquinolina |
| WO2008020302A2 (en) * | 2006-08-17 | 2008-02-21 | Pfizer Products Inc. | Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors |
| US8796267B2 (en) | 2006-10-23 | 2014-08-05 | Concert Pharmaceuticals, Inc. | Oxazolidinone derivatives and methods of use |
| MX2009008465A (es) | 2007-02-15 | 2009-08-20 | Hoffmann La Roche | Nuevas 2-aminooxazolinas como ligandos de taar1. |
| CA2686545C (en) | 2007-04-19 | 2010-11-02 | Concert Pharmaceuticals Inc. | Deuterated morpholinyl compounds |
| US7531685B2 (en) | 2007-06-01 | 2009-05-12 | Protia, Llc | Deuterium-enriched oxybutynin |
| WO2009025823A1 (en) | 2007-08-21 | 2009-02-26 | Amgen Inc. | Phosphodiesterase 10 inhibitors |
| WO2009025839A2 (en) | 2007-08-22 | 2009-02-26 | Amgen Inc. | Phosphodiesterase 10 inhibitors |
| US20090054434A1 (en) | 2007-08-23 | 2009-02-26 | Amgen Inc. | Isoquinolone derivatives as phosphodiesterase 10 inhibitors |
| WO2009035598A1 (en) | 2007-09-10 | 2009-03-19 | Concert Pharmaceuticals, Inc. | Deuterated pirfenidone |
| US20090118238A1 (en) | 2007-09-17 | 2009-05-07 | Protia, Llc | Deuterium-enriched alendronate |
| TW200918519A (en) | 2007-09-19 | 2009-05-01 | Lundbeck & Co As H | Cyanoisoquinoline |
| US20090088416A1 (en) | 2007-09-26 | 2009-04-02 | Protia, Llc | Deuterium-enriched lapaquistat |
| US20090082471A1 (en) | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched fingolimod |
| US20090137457A1 (en) | 2007-10-02 | 2009-05-28 | Concert Pharmaceuticals, Inc. | Pyrimidinedione derivatives |
| US8410124B2 (en) | 2007-10-18 | 2013-04-02 | Concert Pharmaceuticals Inc. | Deuterated etravirine |
| US20090105338A1 (en) | 2007-10-18 | 2009-04-23 | Protia, Llc | Deuterium-enriched gabexate mesylate |
| WO2009055006A1 (en) | 2007-10-26 | 2009-04-30 | Concert Pharmaceuticals, Inc. | Deuterated darunavir |
| EP2225248A1 (en) | 2007-11-30 | 2010-09-08 | Wyeth LLC | Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |
| WO2009070583A1 (en) | 2007-11-30 | 2009-06-04 | Wyeth | Pyrido[3,2-e]pyrazines, process for preparing the same, and their use as inhibitors of phosphodiesterase 10 |
| WO2009068246A2 (en) | 2007-11-30 | 2009-06-04 | Elbion Gmbh | Methods of treating obesity and metabolic disorders |
| US20090143391A1 (en) | 2007-11-30 | 2009-06-04 | Norbert Hofgen | Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10 |
| US20130116241A1 (en) * | 2011-11-09 | 2013-05-09 | Abbvie Inc. | Novel inhibitor compounds of phosphodiesterase type 10a |
-
2012
- 2012-10-25 US US13/660,524 patent/US20130116241A1/en not_active Abandoned
- 2012-10-29 US US13/663,008 patent/US9273068B2/en not_active Expired - Fee Related
- 2012-11-08 CA CA2852604A patent/CA2852604A1/en not_active Abandoned
- 2012-11-08 AU AU2012334074A patent/AU2012334074A1/en not_active Abandoned
- 2012-11-08 PE PE2014000642A patent/PE20141938A1/es not_active Application Discontinuation
- 2012-11-08 RU RU2014123316/04A patent/RU2014123316A/ru not_active Application Discontinuation
- 2012-11-08 WO PCT/EP2012/072150 patent/WO2013068470A1/en not_active Ceased
- 2012-11-08 SG SG11201402142VA patent/SG11201402142VA/en unknown
- 2012-11-08 AR ARP120104208A patent/AR088801A1/es unknown
- 2012-11-08 KR KR1020147015427A patent/KR20140097318A/ko not_active Withdrawn
- 2012-11-08 EP EP12784578.2A patent/EP2776418B1/en not_active Not-in-force
- 2012-11-08 CN CN201280052929.8A patent/CN104053654A/zh active Pending
- 2012-11-08 HK HK15101856.4A patent/HK1201519A1/xx unknown
- 2012-11-08 JP JP2014540459A patent/JP2014534976A/ja active Pending
- 2012-11-08 ES ES12784578T patent/ES2620531T3/es active Active
- 2012-11-08 BR BR112014011284A patent/BR112014011284A2/pt not_active IP Right Cessation
- 2012-11-08 MX MX2014005714A patent/MX2014005714A/es unknown
- 2012-11-08 PH PH1/2014/500877A patent/PH12014500877A1/en unknown
- 2012-11-09 TW TW101141932A patent/TW201326153A/zh unknown
- 2012-11-09 UY UY0001034445A patent/UY34445A/es not_active Application Discontinuation
-
2014
- 2014-04-23 ZA ZA2014/02966A patent/ZA201402966B/en unknown
- 2014-04-29 IL IL232358A patent/IL232358A0/en unknown
- 2014-05-07 GT GT201400089A patent/GT201400089A/es unknown
- 2014-05-08 DO DO2014000097A patent/DOP2014000097A/es unknown
- 2014-05-08 CL CL2014001212A patent/CL2014001212A1/es unknown
- 2014-05-14 CR CR20140223A patent/CR20140223A/es unknown
- 2014-06-04 CO CO14119455A patent/CO7030959A2/es unknown
-
2016
- 2016-01-18 US US14/997,997 patent/US9657034B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201402966B (en) | 2017-08-30 |
| KR20140097318A (ko) | 2014-08-06 |
| GT201400089A (es) | 2015-09-30 |
| US9273068B2 (en) | 2016-03-01 |
| IL232358A0 (en) | 2014-07-01 |
| NZ623727A (en) | 2016-06-24 |
| ES2620531T3 (es) | 2017-06-28 |
| EP2776418A1 (en) | 2014-09-17 |
| TW201326153A (zh) | 2013-07-01 |
| CN104053654A (zh) | 2014-09-17 |
| CL2014001212A1 (es) | 2014-11-28 |
| HK1201519A1 (en) | 2015-09-04 |
| US20160137668A1 (en) | 2016-05-19 |
| AR088801A1 (es) | 2014-07-10 |
| EP2776418B1 (en) | 2017-01-04 |
| CA2852604A1 (en) | 2013-05-16 |
| CO7030959A2 (es) | 2014-08-21 |
| DOP2014000097A (es) | 2014-07-15 |
| US9657034B2 (en) | 2017-05-23 |
| PH12014500877A1 (en) | 2014-05-26 |
| US20130116241A1 (en) | 2013-05-09 |
| WO2013068470A1 (en) | 2013-05-16 |
| AU2012334074A1 (en) | 2014-05-01 |
| JP2014534976A (ja) | 2014-12-25 |
| BR112014011284A2 (pt) | 2017-05-02 |
| UY34445A (es) | 2013-06-28 |
| SG11201402142VA (en) | 2014-06-27 |
| CR20140223A (es) | 2014-09-09 |
| MX2014005714A (es) | 2014-09-04 |
| PE20141938A1 (es) | 2014-12-28 |
| US20130116233A1 (en) | 2013-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014123316A (ru) | Ингибиторы фосфодиэстеразы типа 10а | |
| JP2014534976A5 (enExample) | ||
| RU2014102962A (ru) | Новые соединения-ингибиторы фосфодиэстеразы типа 10а | |
| US12233062B2 (en) | Heterocyclic derivatives useful as SHP2 inhibitors | |
| JP2014506929A5 (enExample) | ||
| JP2020522570A5 (enExample) | ||
| RU2473549C2 (ru) | Пиримидиновые соединения, композиции и способы применения | |
| JP2015504057A5 (enExample) | ||
| JP2021503004A5 (enExample) | ||
| KR101812357B1 (ko) | Ｃｄｋ4/6의 억제제로서의 피롤로피리미딘 화합물 | |
| RU2016135637A (ru) | 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение | |
| WO2025049746A1 (en) | Compositions comprising werner syndrome helicase inhibitors and methods of using the same | |
| KR101286323B1 (ko) | 스피로-옥스인돌 화합물 및 치료제로서의 그의 용도 | |
| HRP20120105T1 (hr) | Aminoheterociklički spojevi | |
| JP2017505327A5 (enExample) | ||
| JP2012505895A5 (enExample) | ||
| AU2010265971B2 (en) | Heterocyclic compounds and their uses as inhibitors of PI3 K activity | |
| JP2015537010A5 (enExample) | ||
| JP2021504380A5 (enExample) | ||
| JP2021506941A5 (enExample) | ||
| JP2015522002A5 (enExample) | ||
| RU2015122895A (ru) | Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта | |
| AU2017277732A1 (en) | New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| JP2024096702A (ja) | モノアシルグリセロールリパーゼ調節因子 | |
| JP2009509964A5 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20170227 |